Incyte Investor Conference Update

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq: INCY) has updated its presentation time at the following investor conference:

• JMP Securities Hematology & Oncology Forum (Virtual) on Thursday, June 18, 2020, now at 3:00 p.m. (EDT).

The presentation at the BMO Prescriptions for Success Healthcare Conference (Virtual) on Tuesday, June 23, 2020 at 1:30 p.m. (EDT) is unchanged.

The presentations for both conferences will be webcast live and can be accessed at Investor.Incyte.com. Replays will be available for 30 days.

About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200617005085/en/

Media
Catalina Loveman, +1 302 498 6171
[email protected]

Investors
Michael Booth, DPhil, +1 302 498 5914
[email protected]

Source: Incyte

You May Also Be Interested In

• Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged P
• Why Assurance Garage Door Repair Is Recognized as the #1 Garage Door Company in Broken Arrow, Oklahoma
• Saudi Arabia to Host Second Consultative Meeting for the 11th World Water Forum